Following Ypso-Facto’s Best Poster Award at BioProcess International Europe, our Co-CEO Edouard Nicoud spoke with BioProcess Insider editor Joshua Abbott about how mechanistic modeling can accelerate downstream process development — with a focus on mixed-mode chromatography.
The discussion centered on the CALIPSO project, a 5-year collaboration with Sanofi supported by the French government, aiming to revolutionize antibody purification. Our objectives :
- Reduce experimental workload
- Shorten development timelines
- Enable faster, more informed process decisions through modeling